MLA Diagnostics

Healthtech · NL

DNA methylation-based molecular prognostic test for early-stage melanoma.

In the network

Shares the most investors with (number = shared investors):

Create a free EquityFlow account to see MLA Diagnostics's 1 funding round, 3 investors, 12 similar companies.